Using economic evidence to support policy decisions to fund interventions for non-communicable diseases
Authors:
Open Access
Abstract
Economic analysis of interventions to reduce non-communicable diseases can encourage countries to increase investment, say Melanie Bertram and colleaguesKeywords
This publication has 7 references indexed in Scilit:
- Donors, non-communicable diseases and universal health coverage to high-quality healthcare: an opportunity for action on global functions for healthJournal of Epidemiology and Community Health, 2018
- Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment servicesThe Lancet, 2018
- Building collaborations to integrate economics into noncommunicable disease actionRevista Panamericana de Salud Pública, 2018
- Advancing the economics of noncommunicable diseases in the AmericasRevista Panamericana de Salud Pública, 2018
- The economic burden of noncommunicable diseases and mental health conditions: results for Costa Rica, Jamaica, and PeruRevista Panamericana de Salud Pública, 2018
- Financing national non-communicable disease responsesGlobal Health Action, 2017
- Where Have All the Donors Gone? Scarce Donor Funding for Non-Communicable DiseasesSSRN Electronic Journal, 2010